FEATURED/ARCHIVES (24/04/24)
×
Methylphenidate for Apathy in Community-Dwelling Older Veterans with Mild Alzheimer’s Disease: A Double-Blind, Randomized, Placebo-Controlled Trial · September 2017
Articles
American Journal of Psychiatry
×
Successful Combination Therapy of Trazodone and Fluvoxamine for Pica in Alzheimer’s Disease: A Case Report · July 2021
Articles
Frontiers in Psychiatry
×
Antidepressants in Alzheimer’s Disease: A Focus on the Role of Mirtazapine · September 2021
Articles
Pharmaceuticals
×
Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes from the CATIE-AD Effectiveness Trial · July 2008
Articles
American Journal of Psychiatry
×
Acetylcholinesterase Inhibitors Combined with Memantine for Moderate to Severe Alzheimer’s Disease: A Meta-Analysis · June 2019
Articles
Swiss Medical Weekly
×
Anti-Amyloid Monoclonal Antibodies Are Transformative Treatments that Redefine Alzheimer’s Disease Therapeutics · April 2023
Articles
Drugs
×
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease · March 2020
Articles
International Journal of Molecular Sciences
×
The Association of Multiple Anti-Hypertensive Medication Classes with Alzheimer’s Disease Incidence Across Sex, Race, and Ethnicity · November 2018
Articles
PLOS ONE
×
Association of Concomitant Use of Cholinesterase Inhibitors or Memantine with Cognitive Decline in Alzheimer Clinical Trials: A Meta-Analysis · November 2018
Articles
JAMA Network Open
×
Benzodiazepine Use and Risk of Developing Alzheimer’s Disease: A Case-Control Study Based on Swiss Claims Data · January 2017
Abstracts
CNS Drugs
×
Analyzing the Impact of 23 Mg/Day Donepezil on Language Dysfunction in Moderate to Severe Alzheimer’s Disease · June 2011
Articles
Alzheimer’s Research and Therapy
×
Antidementia Drug Use among Community-Dwelling Individuals with Alzheimer’s Disease in Finland: A Nationwide Register-Based Study · June 2014
Articles
NCBI>International Clinical Psychopharmacology
×
The Association of Antidepressant Drug Usage with Cognitive Impairment or Dementia, Including Alzheimer Disease: A Systematic Review and Meta-Analysis · December 2016
Articles
Depression and Anxiety
×
Levetiracetam May Slow Progression to Alzheimer’s (Meetings-Events) · July 2011
Abstracts (Summaries)
Medscape>Alzheimer’s Association
×
Once-Daily Transdermal Rivastigmine in the Treatment of Alzheimer’s Disease · November 2008
Articles
Drug Design, Development and Therapy
×
Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis · April 2015
Articles
PLOS ONE
×
Evaluating the Cost Effectiveness of Donepezil in the Treatment of Alzheimer’s Disease in Germany Using Discrete Event Simulation · February 2012
Articles
BMC Neurology
×
The Transdermal Formulation of Rivastigmine Improves Caregiver Burden and Treatment Adherence of Patients with Alzheimer’s Disease Under Daily Practice Conditions · March 2014
Articles
International Journal of Clinical Practice
×
Clinical Effectiveness of Rivastigmine Monotherapy and Combination Therapy in Alzheimer’s Patients · December 2012
Articles
CNS Neuroscience and Therapeutics